Abstract
The field of quantitative structure activity relationships (QSAR) has evolved into an integral tool for pharmaceutical discovery. It is presently an accessible technology, as can be shown by the number papers which are easily found through PubMed literature searches. At one level, QSAR is used routinely and invisibly as an aid for the bench chemist for logP, logS, pKa/pKb, metabolic stability and other such properties. Chemoinformaticians and computational chemists develop models from scratch for less routine purposes associated with lead optimization around a single target or library design around a target family such as kinase, ion channel or GPCR inhibitors. Regardless of the differences in frequency of use and the end user, any successful QSAR is successful because it rests on appropriate mathematics linking valid data and relevant descriptors. Though success is defined by the end user, the QSAR originator is well advised to validate his model and understand how it performs in different situations. The present review will cover QSAR from the ground up as it is used in pharmaceutical research environments. It will focus towards larger dataset methodologies (a minimum 100 of compounds) and by consequence will focus on 2D descriptors. It will start with the critical base of data, descriptors, equations and validation methods. It will review the broadly used and invisible QSARs for logP, pKa/pKb and metabolic stability. The review will then present progress in QSARs of broad interest which are under active development: 1) hERG liability models, 2) modeling for 2a) drug-likeness and related properties, 2b) kinase ligand likeness and 2c) GPCR ligand likeness.
Keywords: QSAR, QSAR validation, QSAR 2D descriptors, Focus library
Current Topics in Medicinal Chemistry
Title: QSAR in the Pharmaceutical Research Setting: QSAR Models for Broad, Large Problems
Volume: 10 Issue: 6
Author(s): D.G. Sprous, R.K. Palmer, J. T. Swanson and M. Lawless
Affiliation:
Keywords: QSAR, QSAR validation, QSAR 2D descriptors, Focus library
Abstract: The field of quantitative structure activity relationships (QSAR) has evolved into an integral tool for pharmaceutical discovery. It is presently an accessible technology, as can be shown by the number papers which are easily found through PubMed literature searches. At one level, QSAR is used routinely and invisibly as an aid for the bench chemist for logP, logS, pKa/pKb, metabolic stability and other such properties. Chemoinformaticians and computational chemists develop models from scratch for less routine purposes associated with lead optimization around a single target or library design around a target family such as kinase, ion channel or GPCR inhibitors. Regardless of the differences in frequency of use and the end user, any successful QSAR is successful because it rests on appropriate mathematics linking valid data and relevant descriptors. Though success is defined by the end user, the QSAR originator is well advised to validate his model and understand how it performs in different situations. The present review will cover QSAR from the ground up as it is used in pharmaceutical research environments. It will focus towards larger dataset methodologies (a minimum 100 of compounds) and by consequence will focus on 2D descriptors. It will start with the critical base of data, descriptors, equations and validation methods. It will review the broadly used and invisible QSARs for logP, pKa/pKb and metabolic stability. The review will then present progress in QSARs of broad interest which are under active development: 1) hERG liability models, 2) modeling for 2a) drug-likeness and related properties, 2b) kinase ligand likeness and 2c) GPCR ligand likeness.
Export Options
About this article
Cite this article as:
Sprous D.G., Palmer R.K., Swanson J. T. and Lawless M., QSAR in the Pharmaceutical Research Setting: QSAR Models for Broad, Large Problems, Current Topics in Medicinal Chemistry 2010; 10 (6) . https://dx.doi.org/10.2174/156802610791111506
DOI https://dx.doi.org/10.2174/156802610791111506 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Life Threatening and Fatal Contrast Media Reactions: Pathomechanisms, Diagnosis, Prevention and Drug Management
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Cardiovascular Magnetic Resonance Imaging: State of the Art
Current Cardiology Reviews Phentermine and Topiramate Extended-Release for the Obesity: New Kids on the Block
Recent Patents on Cardiovascular Drug Discovery Immunophilins and Cardiovascular Complications
Current Medicinal Chemistry Surgical Treatment of Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension
Current Pharmaceutical Design Managing Comorbidity in COPD: A Difficult Task
Current Drug Targets Treating COPD in Older and Oldest Old Patients
Current Pharmaceutical Design Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs
Current Pharmaceutical Design Prognostic Role of miRNAs in Coronary Artery Disease
Current Topics in Medicinal Chemistry How to Fluorescently Label the Potassium Channel: A Case in hERG
Current Medicinal Chemistry Pathophysiological Insights into Atrial Fibrillation Following Cardiac Surgery: Implications for Current Pharmaceutical Design
Current Pharmaceutical Design G Protein-Activated Inwardly Rectifying Potassium Channels as Potential Therapeutic Targets
Current Pharmaceutical Design Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Current Drug Metabolism Editorial (Thematic Issues: Pharmacological Mechanisms and Interventions in Ischemia/ Reperfusion-Induced Injury)
Current Pharmaceutical Design Free Radicals in Diseases and Potential Role of Phytoconstituents-A Cause with Emerging Importance
Current Chemical Biology Improving Pediatric Survival from Resuscitation Events: The Role and Organization of Hospital-based Rapid Response Systems and Code Teams
Current Pediatric Reviews Non-Hodgkins Lymphoma: Review of Conventional Treatments
Current Pharmaceutical Biotechnology Vascular Calcification and not Arrhythmia in Idiopathic Atrial Fibrillation Associates with Sex Differences in Diabetic Microvascular Injury miRNA Profiles
MicroRNA Kv1.5 Blockers for the Treatment of Atrial Fibrillation: Approaches to Optimization of Potency and Selectivity and Translation to In Vivo Pharmacology
Current Topics in Medicinal Chemistry The Rabbit as an Experimental and Production Animal: From Genomics to Proteomics
Current Protein & Peptide Science